22 04 08 new CGO CMO

CS MEDICA A/S appoints new CGO/CMO

CS MEDICA A/S (” CS MEDICA” or the” Company”) announces today that as of May 1, 2022 Heidi Ahlefeldt-Laurvig will take over as Chief Growth Officer (CGO) and Chief Marketing Officer (CMO).

CS MEDICA has appointed Heidi Ahlefeldt-Laurvig as the new Chief Marketing & Growth Officer. Heidi has more than 15 years of experience delivering profitable growth and building brands. With a successful track record in marketing and digital transformation, Heidi works seamlessly in an organization due to her different roles within sales, brand management, and marketing, retail, and e-commerce which will match the team and high growth expectations for CS MEDICA.

Most recently Heidi comes from a position as Chief Commercial Officer responsible for Marketing & E-commerce for Life Extension Europe, an e-commerce company distributing premium brands within vitamins & supplements to over 30 countries. In her role, she helped transform and grow the Company from a product-driven webshop to a data-driven e-commerce platform with multiple strong brands. Companies Heidi also has experience from are amongst others, Dagrofa/MENY, Coop/Kvickly, Cloetta, L’Oréal, Gillette/P&G, and YouSee.

Heidi brings relevant and significant experience to help boost growth and launch plans to bring CS MEDICA’s products onto new markets and platforms. As the new CGO/CMO, Heidi will lead, manage, and develop the companies’ two subsidiaries’ branding, marketing, and communication. Additionally, she will focus on growing an agile, digital marketing team and onboarding CanNordic’s products on Amazon in Europe and, subsequently, the USA and Canada in collaboration with international partners.

Comment from Lone Henriksen:
I am happy to welcome Heidi Ahlefeldt-Laurvig as CGO/CMO. Heidi has extensive experience in marketing and digitalization and possesses a rare toolbox encompassing a complete set of skills corresponding to our ambitions. With Heidi’s expertise, I am confident that she will be an important asset in our continued growth journey.”

Heide will take on the role of CGO/CMO on May 1, 2022.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.